VTGN Stock Catalyst: SRX Global Acquires Stake in Vistagen Therapeutics

Aug 4, 2026 · 5:01am ET

The acquisition was announced on August 4, 2026.

Max move

+67.3%

High of day $0.41

Sparker timei

5:01am ET

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

SRX Global Inc. has acquired a stake in Vistagen Therapeutics, Inc. (Nasdaq: VTGN). The acquisition was announced on August 4, 2026.

Vistagen Therapeutics has a free float of 35,040,484 shares and 44,376,911 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time VTGN sparks.

Catch the next VTGN-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.